Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Compensated Liver Cirrhosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02325622
What this trial is testing

Relationships Between Mean Plasma Glucose and HbA1c in Cirrhotic Patients With Hepatogenous Diabetes

Who this might be right for
Liver CirrhosisDiabetes Mellitus
Yonsei University 48
Not applicableNot Yet RecruitingNCT07450651
What this trial is testing

Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis

Who this might be right for
Hepatitis B Virus Related CirrhosisPortal Hypertension Related to CirrhosisEsophagogastric Varices
Beijing Friendship Hospital 150
Not applicableUnknownNCT06144437
What this trial is testing

Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLD

Who this might be right for
Liver CirrhosisLiver FibrosisPortal Hypertension
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Not applicableStudy completedNCT01609049
What this trial is testing

An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,496
Large-scale testing (Phase 3)WithdrawnNCT02824354
What this trial is testing

Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.

Who this might be right for
CirrhosisAlcohol DependenceNalmefene
Centre Hospitalier Universitaire, Amiens
Testing effectiveness (Phase 2)Study completedNCT01409356
What this trial is testing

Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and Cirrhosis

Who this might be right for
Compensated CirrhosisObesity
Hospital Clinic of Barcelona 60
Not applicableLooking for participantsNCT07122622
What this trial is testing

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

Who this might be right for
Portal Hypertension Related to CirrhosisEsophageal Varices
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 450
Not applicableNot Yet RecruitingNCT06537466
What this trial is testing

Ketogenic Diet in MASLD-related cACLD

Who this might be right for
Steatohepatitis, NonalcoholicSteatosis of LiverCirrhosis, Liver
University of Palermo 50
Not applicableNot Yet RecruitingNCT07183293
What this trial is testing

A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis

Who this might be right for
HBV-related Liver Cirrhosis
Xiamen Humanity Hospital 30
Not applicableUnknownNCT06147934
What this trial is testing

Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD

Who this might be right for
Liver FibrosisLiver Cirrhosis
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Not applicableUnknownNCT04196998
What this trial is testing

Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis

Who this might be right for
Hepatitis BCompensated Cirrhosis
Third Affiliated Hospital, Sun Yat-Sen University 150
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableUnknownNCT01148277
What this trial is testing

Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensated Cirrhosis Child A-B

Who this might be right for
Liver Disease
Ziv Hospital 90
Not applicableUnknownNCT06147518
What this trial is testing

To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis

Who this might be right for
Compensated CirrhosisDecompensated Cirrhosis
Institute of Liver and Biliary Sciences, India 240
Not applicableUnknownNCT04160897
What this trial is testing

Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

Who this might be right for
Hepatitis B, ChronicHepatocellular CarcinomaCompensated Cirrhosis
Qing XIe 4,000
Large-scale testing (Phase 3)Ended earlyNCT01342705
What this trial is testing

Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis

Who this might be right for
Alcoholic CirrhosisIron Overload
Assistance Publique - Hôpitaux de Paris 17
Early research (Phase 1)Study completedNCT01909778
What this trial is testing

Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis

Who this might be right for
Hepatitis CLiver Cirrhosis
Boehringer Ingelheim 2
Testing effectiveness (Phase 2)Study completedNCT01636778
What this trial is testing

Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 45
Not applicableUnknownNCT03778775
What this trial is testing

Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (Pan-CHESS1801)

Who this might be right for
Compensated Liver CirrhosisGastroesophageal Varices Bleeding
Nanfang Hospital, Southern Medical University 200
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Next Page
15